GenoMEL logo
 
 
  GenoMEL is an international research consortium coordinated by the University of Leeds.
  University of Leeds
  home
  Kies een andere taal
  Programma
  Lidmaatschap
  Deelnemers
  Medische informatie
  Patiënteninformatie
  Artikelen
  Exchange Programme
  data sharing
  Knowledge Transfer
  Leden sectie
  Stage III Melanoma Research Group
  PharmacoGenoMEL
  Contact
  Site Map
  media
  Doorzoeken van de site
  Interessante links
  Nieuws
  Toegang
  Terms and Conditions
Privacy Statement
  Translations by: The LUMC team, particularly Frans van Nieuwpoort
Participants
Cesena, USA
 
Group Details Group Members Group Publications
 
Group Details
   

Publications

 
 

Landi MT, Calista D, Landi G, Bernucci I, Bertazzi PA, Clark WH Jr, Goldstein AM, Tucker MA.
Clinical characteristics of 20 Italian melanoma-prone families.
Arch Dermatol 1999;135:1554-1555.

http://archderm.ama-assn.org/cgi/content/full/135/12/1554

 
 

Calista D, Landi MT, Minghetti P, Landi G.
Aspetti genetici del melanoma cutaneo familiare.
G Ital Dermatol Venereol 2000;135:63-69.

 
 

Calista D, Goldstein AM, Landi MT.
Familial melanoma aggregation in north-eastern Italy.
J Invest Dermatol 2000;115:764-765.

http://www.blackwell-synergy.com/links/doi/10.1046/j.1523-1747.2000.00124-4.x/full/

 
 

Calista D, Landi MT.
Cutaneous Malignant Melanoma.
Nuovi Argomenti di Medicina 2000;4/5:73-76.

 
 

Landi MT, Baccarelli A, Calista D, Fears T, Landi G.
Glucocorticoid use and melanoma risk.
Int J Cancer 2001;94:302-303.

http://www3.interscience.wiley.com/cgi-bin/fulltext/85008156/HTMLSTART

 
 

Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, Tucker MA, Landi G.
Combined risk factors for melanoma in a Mediterranean population.
Br J Cancer 2001; 85:1304-1310.

http://www.nature.com/cgi-taf/DynaPage.taf?file=/bjc/journal/v85/n9/abs/6692029a.html&dynoptions=doi1095689888

 
 

Landi MT, Baccarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M, Grossman L.
DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma.
J Natl Cancer Inst 2002;94:94-101.

http://jncicancerspectrum.oupjournals.org/cgi/content/full/jnci;94/2/94

 
 

Landi MT, Baccarelli A, Pesatori A, Hedayati M, Grossman L, Tucker MA, Tarone RE.
Response to Pedeaux et al.Re: DNA repair, dysplastic nevi and sunlight sensitivity in the development of cutaneous malignant melanoma.
J Natl Cancer Inst 2002;94:773-774.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstr act&list_uids=12011229

 
 

Brenner AV, Lubin JH, Calista D, Landi MT.
Instrumental measurements of skin color and skin ultraviolet light sensitivity and risk of cutaneous malignant melanoma: a case-control study in an Italian population.
Am J Epidemiol 2002;156:353-362.

http://aje.oupjournals.org/cgi/content/full/156/4/353

 
 

Baccarelli A, Landi MT.
Risk factors of malignant skin melanoma in Italian population: review of results of a case-control study.
Epidemiol Prev, 2002;26:293-299.

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstr act&list_uids=12619494

 
 

Baccarelli A, Calista D, Minghetti P, Marinelli B, Albetti B, Hedayati M, Grossman L, Landi G, Struewing JP, Landi MT.
XPD polymorphism, age and dysplastic nevi in the association with cutaneous malignant melanoma risk
Br J Cancer 2004; 90:497-502.

http://www.nature.com/cgi- taf/DynaPage.taf?file=/bjc/journal/v90/n2/abs/6601385a.html&dynoptions=doi10956894 33

 
 

Landi MT, Goldstein A, Tsang S, Munroe D, Modi W, Ter-Minassian M, Steighner R, Dean M, Metheny N, Staats B, Agatep R, Hogg D, Calista D.
Genetic Susceptibility in familial melanoma from North Eastern Italy.
J Med Genet 2004, 41: 557-566.

http://jmg.bmjjournals.com/cgi/content/full/41/7/557

 
 

Landi MT.
Skin color, ultraviolet sensitivity, nevi and DNA repair: risk of cutaneous malignant melanoma in a Mediterranean population. In: Melanoma: from melanocyte to malignancy.
VJ Hearing, SPL Leong, eds. The Humana Press, Inc. (In Press).

 
 
   
 
 
   
website design: NKD | email: info@NKD.org.uk | site: www.NKD.org.uk